# Telmisartan Fixed Dose Combination vs Amlodipine in Hypertensive Patients With Type 2 Diabetes Mellitus

> **NCT00877929** · PHASE3 · COMPLETED · sponsor: **Boehringer Ingelheim** · enrollment: 706 (actual)

## Conditions studied

- Hypertension

## Interventions

- **DRUG:** Telmisartan 80
- **DRUG:** Amlodipine 10
- **DRUG:** Amlodipine 10

## Key facts

- **NCT ID:** NCT00877929
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-02
- **Primary completion:** 2010-05
- **Final completion:** —
- **Target enrollment:** 706 (ACTUAL)
- **Last updated:** 2014-03-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00877929

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00877929, "Telmisartan Fixed Dose Combination vs Amlodipine in Hypertensive Patients With Type 2 Diabetes Mellitus". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT00877929. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*